Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ercole Concia

Showing results (11-20 of 101) with videos related to

Pageof 11
Sort By:
Recenti Progressi in Medicina|November 1, 2007
[CD4+ guided interruption HAART in HIV patients]Dario Antolini, Massimiliano Lanzafame, Emanuela Lattuada, et al.
AIDS Research and Human Retroviruses|July 22, 2009
No influence of nevirapine on vitamin D deficiency in HIV-infected patientsEmanuela Lattuada, Massimiliano Lanzafame, Giacomo Zoppini, et al.
Le Infezioni in Medicina|June 19, 2013
[Pulmonary tuberculosis mimicking a severe community-acquired pneumonia with rhabdomyolysis]Andrea Tedesco, Lorenzo Guglielmetti, Michela Conti, et al.
The Lancet. Infectious Diseases|March 5, 2004
Pneumatocoele formation during Pneumocystis carinii pneumonia in a man with HIV-1 infectionEmanuela Lattuada, Giovanni Puppini, Federica Faggian, et al.
International Journal of STD & AIDS|March 25, 2004
Early detection of lung cancer in high-risk patients with HIV-1 infectionMassimiliano Lanzafame, Romualdo Mazzi, Federica Faggian, et al.
Recenti Progressi in Medicina|July 14, 2004
[No improvement of lipodystrophy syndrome in an HIV-infected patient]Massimiliano Lanzafame, Federica Faggian, Emanuela Lattuada, et al.
Chest|August 11, 2004
Is the recommendation not to use rifampin plus pyrazinamide for latent tuberculosis treatment always imperative?Angelo Cazzadori, Benedetta Allegranzi, Anna Scardigli, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 17, 2010
Adrenal crisis during anti-tuberculosis treatmentLorenzo Guglielmetti, Michela Conti, Chiara Grigolo, et al.
AIDS (London, England)|December 11, 2014
Efavirenz dose reduction in HIV-infected patients: a long-term follow-upMassimiliano Lanzafame, Emanuela Lattuada, Giulia Cucchetto, et al.
Le Infezioni in Medicina|January 10, 2013
Pharmacokinetic exposure and virological efficacy of a reduced atazanavir doseMassimiliano Lanzafame, Emanuela Lattuada, Fabiana Corsini, et al.
Pageof 11

Showing results (11-20 of 101) with videos related to

Sort By:
Pageof 11
Recenti Progressi in Medicina|November 1, 2007
[CD4+ guided interruption HAART in HIV patients]Dario Antolini, Massimiliano Lanzafame, Emanuela Lattuada, et al.
AIDS Research and Human Retroviruses|July 22, 2009
No influence of nevirapine on vitamin D deficiency in HIV-infected patientsEmanuela Lattuada, Massimiliano Lanzafame, Giacomo Zoppini, et al.
Le Infezioni in Medicina|June 19, 2013
[Pulmonary tuberculosis mimicking a severe community-acquired pneumonia with rhabdomyolysis]Andrea Tedesco, Lorenzo Guglielmetti, Michela Conti, et al.
The Lancet. Infectious Diseases|March 5, 2004
Pneumatocoele formation during Pneumocystis carinii pneumonia in a man with HIV-1 infectionEmanuela Lattuada, Giovanni Puppini, Federica Faggian, et al.
International Journal of STD & AIDS|March 25, 2004
Early detection of lung cancer in high-risk patients with HIV-1 infectionMassimiliano Lanzafame, Romualdo Mazzi, Federica Faggian, et al.
Recenti Progressi in Medicina|July 14, 2004
[No improvement of lipodystrophy syndrome in an HIV-infected patient]Massimiliano Lanzafame, Federica Faggian, Emanuela Lattuada, et al.
Chest|August 11, 2004
Is the recommendation not to use rifampin plus pyrazinamide for latent tuberculosis treatment always imperative?Angelo Cazzadori, Benedetta Allegranzi, Anna Scardigli, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 17, 2010
Adrenal crisis during anti-tuberculosis treatmentLorenzo Guglielmetti, Michela Conti, Chiara Grigolo, et al.
AIDS (London, England)|December 11, 2014
Efavirenz dose reduction in HIV-infected patients: a long-term follow-upMassimiliano Lanzafame, Emanuela Lattuada, Giulia Cucchetto, et al.
Le Infezioni in Medicina|January 10, 2013
Pharmacokinetic exposure and virological efficacy of a reduced atazanavir doseMassimiliano Lanzafame, Emanuela Lattuada, Fabiana Corsini, et al.
Pageof 11